Michael Garanzini

Michael Garanzini discloses dealings in Kiora Pharmaceuticals Inc to SEC (Form 4). Between 17 November 2017 and 10 July 2018, the trades on record add up to 3 filings.

Purchases make up the whole of the open-market record (1 purchase). The totals do not cover 1 filing with an undisclosed amount. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 2 share grants. In 2018 alone, the filings show 1 purchase and no sales.

The latest filing, published on 12 July 2018, reports a share grant in Kiora Pharmaceuticals Inc. The last purchase on record was published on 18 April 2018, which is 3,127 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.